Schedule 13G Filing by The Vanguard Group for Insmed Inc

This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of Insmed Inc. securities by The Vanguard Group. The filing states that The Vanguard Group, including its subsidiaries and managed accounts, has the right to receive or direct the sale of dividends and proceeds from the sale of the reported securities. However, it also notes that no single other person has an interest exceeding 5% in these securities. The filing clarifies that an internal realignment on January 12, 2026, led to certain subsidiaries and business divisions of The Vanguard Group, Inc. reporting beneficial ownership separately. Consequently, The Vanguard Group, Inc. no longer claims beneficial ownership of securities held by these disaggregated entities, which continue to pursue the same investment strategies. The reported number of shares beneficially owned and the ownership percentage are stated as 0, with no change in value or shares.